Surgical Oncology Procedures

Rapid Haemostasis and Reduced Transfusion Rates During Surgical Oncology Procedures*,1,6

Medtronic Advanced Energy built the foundation of its early success on innovative products for solid organ procedures. Our monopolar and bipolar devices use patented Transcollation® technology – a combination of RF (radiofrequency) energy and saline – to provide haemostasis and reduce blood loss during surgery.

Surgical technique is important to achieve optimal results with Transcollation technology.  Studies have shown that Transcollation technology used in surgical oncology procedures provides the following clinical benefits:  
  • Reduces blood transfusion rates during and after liver resections1
  • Reduces the need for renal clamping in partial nephrectomies2
  • May reduce post-operative pancreatic leaks following distal pancreatectomy**,3

Procedures where Medtronic devices are commonly used include:

  • Liver Resection
  • Partial Nephrectomy
  • Pancreatectomy

Transcollation technology offers the following benefits by procedure

Liver resection 

Transcollation technology is used to perform liver division while providing haemostasis.


Partial nephrectomy

Transcollation technology is used for blunt dissection of the tumor, to pre-coagulate renal parenchyma, and for residual bleeders from the resection line.   


Distal pancreatectomy  

Transcollation technology is used to treat the tissue prior to resection or seal the cut edge following resection which may reduce post-operative pancreatic leaks following distal pancreatectomy.**,3

*Performance not specifically established in all procedures.
**Performance has been demonstrated in a pre-clinical model.



View References and Clinical Bibliography